chrisvoncsefalvay/vaers-outcomes huggingface dataset:
When she took the second part of the vaccine, this didn't hit until later but her lips tingled and went numb; When she took the second part of the vaccine, this didn't hit until later but her lips tingled and went numb; her arm where she got the shot is inflamed and it is red; it was red where they gave the shot; this achiness is not like what she normally experiences it is like going into her back and burning; this achiness is not like what she normally experiences it is like going into her back and burning; She is having chills; she is hot; frustrated; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received her first dose of BNT162B2 on 28Dec2020 for COVID-19 immunization and she had like a quick reaction, it was a tingling on her tongue and then her tongue went numb. When she took the second part of the vaccine, this didn't hit until later in Jan2021 but her lips tingled and went numb and then she took Benadryl and she was fine. Then last night she was tossing and turning in bed and her arm where she got the shot was inflamed and it was red where they gave the shot. She said usually when she got the flu shot she was achy in that arm and that was about it and she was expecting that but this achiness was not like what she normally experienced it was like going into her back and burning. She did not know what to do she was tired of calling, she called her PCP and they told her to call her job, she worked at a nursing home and she did not know what else to do if she should go to the ER. She was having chills and she was hot. She was very frustrated. The outcome of events tingling lips and numb lips was recovered on unknown date. The outcome of rest events was unknown.  Information on lot and batch number has been requested.
I couldn't raise my head off the pillow; on Friday evening I started experiencing dizziness and Vertigo.On Saturday I couldn't raise my head off the pillow, on Sunday very dizzy. I also feel dizzy now.; on Friday evening I started experiencing dizziness and Vertigo.; The patient received third/booster dose of BNT162b2; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the third/booster dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2590) via an unspecified route of administration in the left arm on 04Nov2021 at 03:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. The medical history included Adult Stills. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included anakinra (KINERET) and vitamins (unspecified); both for unknown indications from unknown dates and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN602) via an unspecified route of administration in the left arm on 17Feb2021 (at the age of 68-years-old) and also second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: NIO207) via an unspecified route of administration in the left arm on 10Mar2021 (at the age of 68-years-old) both as a single dose for COVID-19 immunisation. On 04Nov2021 Thursday evening, the patient felt fine. On 05Nov2021 at 18:00 Friday evening, the patient started experience dizziness and vertigo. On 06Nov2021 (Saturday), the patient could not raise her head off the pillow and on 07Nov2021 Sunday, she was very dizzy. The patient also felt dizzy at the time of this report. The adverse events did not result in doctor or other health care professional office/clinic visit and emergency/room or department or urgent care. Therapeutic measures were taken as a result of the reported events included treatment with meclizine (MANUFACTURER UNKNOWN) tablets prescribed by doctor. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizziness and vertigo were not resolved at the time of this report.
When I received my flu vaccine, my arm was sore for at least a week.  The initial soreness went away, but then I developed a shooting pain that radiates from the injection site down my arm. This occurs a couple of times a day, and is very painful. It is severe enough that I at times put a pain patch on the injection site.
shingles; very painful shingles; This case was reported by a consumer via and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles and pain. Shingles vaccine was discontinued. On an unknown date, the outcome of the shingles and pain were unknown.   It was unknown if the reporter considered the shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient himself/ herself. The age at vaccination was not reported. The patient got the 1st shingle shot and it did not work for him/her. The patient came down with a horrible case of very painful shingles. The patient was asked not to get the second shingles shot due to getting from the first shot. The patient stated that the shot probably worked for thousands of people just not for him/her.
This spontaneous report as received from a nurse refers to 2 patients of unknown age. On 04-JUN-2014 the two patients were vaccinated with M-M-R II, lot# unknown, expiration date: 17-MAY-2014, (dose, route and indication not reported). The nurse stated that M-M-R II had no previous temperature excursions. No adverse symptoms were reported. The reporter did not mention if the patients received any prior doses. Additional information has been requested.
Immediate pain at injection site and deep within the muscle. Aches, fever, chills, vomiting, dizziness, and fainting within 12 hours of injection. Fatigue that lasted 72 hours. Swelling around the eyes that lasted 48 hours.
Left leg swelling, erythema at site and surrounding area by approx. 5 in diameter associated with macular rash on thigh.
p/given vax pt fainted & then vomited; VS were stable; did not seize; father stated pt has epilepsy & sometimes does this under stress; father said pt takes Tegretol & is well controlled;
21JAN98 rash resembling chickenpox 10 on face & 30 abd & 15-20 back;T99;gone w/in 2 days;
severe headache; severe neck ache; fatigue; exhaustion; swollen lymph gland - arm; swollen lymph gland - groin; fever of 100.5; could not move; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (severe headache), MUSCULOSKELETAL DISCOMFORT (severe neck ache), FATIGUE (fatigue), FATIGUE (exhaustion) and LYMPHADENOPATHY (swollen lymph gland - arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL (LISINOPRIL +PHARMA) and VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL) for an unknown indication.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (severe headache), MUSCULOSKELETAL DISCOMFORT (severe neck ache), FATIGUE (fatigue), FATIGUE (exhaustion), LYMPHADENOPATHY (swollen lymph gland - arm), LYMPHADENOPATHY (swollen lymph gland - groin), PYREXIA (fever of 100.5) and HYPOKINESIA (could not move). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, HEADACHE (severe headache), MUSCULOSKELETAL DISCOMFORT (severe neck ache), FATIGUE (fatigue), FATIGUE (exhaustion), LYMPHADENOPATHY (swollen lymph gland - arm), LYMPHADENOPATHY (swollen lymph gland - groin), PYREXIA (fever of 100.5) and HYPOKINESIA (could not move) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.5f (Low) 100.F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications lisinopril, valacyclovir. Treatment details were not provided.
Red rash at vaccination site started  approx. 8 days after vaccination. Red rash, not itchy. Slightly tender. Rash started losing color day 9 and 10.
This spontaneous report was received from a physician via a company representative refers to an approximately 11 to 12 year old male patient. The patient's concurrent conditions and medical history were no provided. On an unknown date, the patient was vaccinated with an unspecified dose of GARDASIL intramuscular injection (anatomical location, lot number and expiration date were not provided). There were no concomitant medications reported. On an unknown date, the patient developed Guillain-Barre syndrome. On an unspecified date, the patient visited the physician's office for medical attention. There was no product quality issue involved. The outcome of Guillain-Barre syndrome was not reported. The reporter physician stated that the patient's parents believed that the child had developed Guillain-Barre, as result of GARDASIL injection, but, the physician did not assess the relatedness of Guillain-Barre syndrome with GARDASIL. Upon internal review Guillain-Barre syndrome was determined to be medically significant. Additional information has been requested.
still having pain in the arm at the injection site of the 1st one; it's just a sensation/it feels like bruised on the inside/or something going on in the muscle; It''s just a sensation. It''s like a muscular pain. It feels like someone one, you know, muscle punched me in my arm. It''s feels like bruised on the inside.; muscular abscess; This is a spontaneous report from a contactable consumer (patient). A 54-years-old female patient received first dose of bnt162b2 (COMIRNATY, Solution for injection, Lot Number: FD8448) via an unspecified route of administration administered in arm left (bicep) on 19Aug2021 as dose 1, single for COVID-19 immunization (age at vaccination: 54-years-old). The patient medical history included: gastrointestinal issues. Patient did not take any other products or medication. She did not have diabetes or blood pressure issue or anything like that. On an unspecified date the patient reported that it will be 2 months, since she had her first Pfizer shot and she was supposed to go and get her second shot tomorrow but she still having pain in the arm at the injection site of the first shot. She added it was just a sensation, like a muscular pain, it feels like someone, muscle punched me in her arm, it feels like bruised on the inside. She felt like she has been knuckle punched in the arm, like there was a bruise or something going on in the muscle. She did not have any kind of swelling or rash or anything noticeable. She talked to her doctor, and they said that she might need a CT scan in case there was some sort of Abs test, or in case there was some intolerance to the vaccine, to evaluate for a muscular abscess and to determine if the vaccine was administered incorrectly or if was a reaction to the vaccine. She had blood work done at her doctor's office last week or may be 2 weeks before. She was tested for a lot of things. testing for vitamin deficiency mostly because she was just going to have lot of different undecided health issues. She further added that everything was normal on her blood work. There was nothing that they found. They found low vitamin D. The number 20 so, it was kind of low vitamin D." The patient did not received treatment for the events. The outcome of the event still having pain in the arm at the injection site of the 1st one was not recovered, and outcome for rest of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Patient was given Kinrix (DTaP/IPV) instead of Pediarix (DTaP/IPV/HepB). Patient tolerated the vaccine well. No fever or any illness reported by the mother.
Doesn't feel well; Heart rate 97; Blood pressure went to 150/91 at 6pm, at 7pm 192/101; Heart rate fluctuating; Fatigued; A Spontaneous report was received from Consumer concerning a 77-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced Blood pressure went to 150/91 at 6pm, at 7pm 192/101, heart rate 97/elevated heart rate or his heart rate was fluctuating, was fatigued and he did not feel well.  The patient's medical history included prostate cancer and bone cancer.   The concomitant medication was not reported.  On 20-Jan-2021 prior to the onset of the event, the patient received their first dose mRNA-1273 (Lot number: 030L20A, Expiration date: not provided), on 17-Feb-2021 second dose was received at 9:00 am (Lot number: 030M20A, Expiration rate: unknown) via intramuscular route for prophylaxis of COVID-19 infection.   On 17-Feb-2021, after administration of vaccine patient experienced Blood pressure went to 150/91 at 6pm, at 7pm 192/101, heart rate 97/elevated heart rate or his heart rate was fluctuating, was fatigued but was not sure if that was part of the vaccine or heart medication. On an unknown date patient did not feel well.  Action taken with the mRNA-1273 in response to the events was not provided.   The outcome was unknown for all events. Treatment was included Clonidine 0.2ml.; Reporter's Comments: This case concerns a 77 Y/O M with PMHx of prostate cancer and bone cancer who had serious unexpected Blood pressure increased and Heart rate increased along with a NS unexpected Heart rate irregular, malaise, and NS expected fatigue.  Event onset 29 days after first dose mRNA-1273. Treated with clonidine. Event outcomes unknown. Based on current available information and temporal association between use of the product and the start date of the event, a causal relationship cannot be excluded.
Patient with urticaria after immunizations today. 1.5cm wheal near right axilla with surrounding about 8cm of blotchy erythema. 1 small hive about 2mm left torso, few small pink papules at mouth - observed for 30 minutes after given Benadryl 1.25 tsp. Wheal size undefined surrounding erythema is less. Left torso have remains, perioral papule remains. No progression. No facial swelling. Lungs CTA. HR  = 104 table. Plan - referred to allergist.
Rash on arm and blurry vision blurry occurred on 10/09/12 and continued through 10/10/12.
Migraine that was very faint before had the COVID-19 vaccine, just got worst; Feelings of nausea; Headache again; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 30Mar2021 at 14:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included sleep apnea and migraine headache. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included acetylsalicylic acid/ caffeine/ paracetamol (EXCEDRIN) for migraine headache and from unknown start date. The patient previously received codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. On 30Mar2021 at 17:30, the patient experienced migraine that was very faint before had the COVID-19 vaccine which just got worst along with feelings of nausea that got worst throughout the evening & into the morning of 31Mar2021 and headache again occurred. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraine that was very faint before had the COVID-19 vaccine, just got worst, feelings of nausea and headache again were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Chills; Headache; Fever; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 92-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 30Mar2021 at 11:30 (at the age of 92-years-old) as a single dose for COVID-19 immunisation. The medical history included A-Fib (Atrial fibrillation) and COVID-19. It was not sure whether the patient had any known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 31Mar2021, the patient experienced chills, headache, fever and extreme fatigue. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, headache, fever and extreme fatigue was recovered with sequelae on an unknown date in 2021.    No follow-up attempts are needed. No further information is expected.
pt devel fever 26FEB94-had sz described on ER sheet arms & legs shaking, eyes rolled back, lasted 15 mins; Ok afterward; pt found to have OM;
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 80-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included guillain barre syndrome (had Guillain-Barre syndrome about 15 years ago). Previously administered products included Shingrix with an associated reaction of injection site swelling (1st dose received on 22nd April 2021 and also experienced injection site pain, sluggishness and pain in arm, refer case US2021250234). Concurrent medical conditions included lower extremities weakness of (has some slight weakness in her left leg). On 21st June 2021, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 21st June 2021, immediately after receiving Shingrix, the patient experienced injection site pain and injection site swelling. In July 2021, the patient experienced stiff joint, muscle tightness, decrease in coordination, ataxia, weakness of limbs, leg pain and pain ankle. On an unknown date, the patient experienced condition aggravated. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site pain and injection site swelling were recovered/ resolved and the outcome of the stiff joint, muscle tightness, ataxia, weakness of limbs, leg pain and pain ankle were not recovered/not resolved and the outcome of the decrease in coordination and condition aggravated were unknown. The reporter considered the injection site pain to be related to Shingrix. It was unknown if the reporter considered the injection site swelling, stiff joint, muscle tightness, decrease in coordination, ataxia, weakness of limbs, leg pain, pain ankle and condition aggravated to be related to Shingrix. Additional details were provided are as follows: The patient self-reported this case. The patient had a history of Guillian Barr Syndrome (about 15 years ago) and was recovered other than some slight weakness in her left leg. The patient received a dose of Shingrix in left deltoid and immediately had soreness at injection site that lasted several days. Less than a day after receiving the vaccination, the patient had swollen upper left arm. About a month ago, after receiving the vaccination, the patient had experienced weakness of the legs and arms, tightness in her ankles and legs, stiffness of her joints, ataxia, pain in her ankles and legs and a loss of coordination. In 2021, less than 6 months after receiving vaccination, the patient got increased weakness in her left leg and the weakness spread to her right leg and both arms. The reporter stated that these side effects felt exactly the same as the effects of Guillian Barr Syndrome when she had previously been diagnosed. The reporter called to ask if the Shingrix vaccine could reactive Guillian Barr Syndrome. The reporter did not have any further healthcare professional's contact information. The reporter consented to follow-up.; Sender's Comments: US-GLAXOSMITHKLINE-US2021250234:Same patient, different dose.
Information ahs been received from a healthcare pharmacy student concerning an approx 87 year old male with no know allergies and history of cold agglutination disease who within the year approx 2005 was vaccianted with a dose of Pneumococcal 23v polysaccharide vaccine. Concomitant therapy included prednisone. On 8/16/05 the pt had a titer which showed a response to only 6 serotypes. There was no other information available regarding the pts adverse event. The adverse event did not improve and the pt is not recovered. There was no product quality complaint reported. The pt sought unspecified medical attention. Additional information has been requested.
Narrative:  The developed the same day as the vaccination and lasted for about 2 days prior to spontaneously resolving without intervention. He denied other common adverse effects including nausea, vomiting, and diarrhea.
Vaccine was administered beyond use date, but before the exp. date of 11/24/2022.
Morning of Friday, Nov. 26, woke up feeling slightly dizzy and nauseous.  Nausea worsened and I began vomiting, with frequency of vomiting increasing throughout the day.  Toward evening, unable to retain fluids, I went to local ER and received IV fluids and Reglan, which stopped vomiting.  Saturday, Nov. 27, I began to notice I was having mild trouble with speech, where it was taking me multiple tries to verbalize sentences correctly (words were coming out in a jumble).  Sunday, Nov. 28, I noticed I was also having trouble remembering names of several people I have known for 15+ years, and over the following weeks noticed other mild cognitive symptoms mostly related to speech and memory (mostly being unable to find the correct word to describe things, which has never been an issue for me), and often having to re-type things multiple times due to incorrect spelling or jumbling letters of a word while typing.
10 minutes after vaccine: patient complained of headache. 2 hours after vaccines, patient stated she was nauseous and had vomited once. Shortly after, she vomited again and stated she felt better. 8 hours after vaccines, patient stated the headache and nausea were reduced, no more vomiting.
*DIARHHEA FOR 15 DAYS, FUSSINESS, GROGGY *10/22/10 DOCTOR PUT HIM ON ONLY PEDIALITE WHICH DID NOT STOP THE DIARHHEA *10/27/10 DOCTOR PUT HIM ON SOY FORMULA AND CEREAL,  *10/29/10 DIARHHEA STARTED GETTING BETTER *11/5/10 PATIENT STILL HAS PROBLEMS GASTROINTESTINALLY, RANDOM DIARHHEA, FUSSY,
STILL CAN NOT FULLY LIFT ARM OR OPEN HAND AFTER 1 WEEK
Patient reports that she developed anxiety 3 days after receiving influenza vaccine at store clinic. Was seen by her physician - began on buspirone 10/29/02. Anxiety not improving and seen by physician 11/18 and dosage increased. Patient states has had short, mild episodes of anxiety in past - no treatment required.